Correlation Between Adaptimmune Therapeutics and Evofem Biosciences

Can any of the company-specific risk be diversified away by investing in both Adaptimmune Therapeutics and Evofem Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Adaptimmune Therapeutics and Evofem Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Adaptimmune Therapeutics Plc and Evofem Biosciences, you can compare the effects of market volatilities on Adaptimmune Therapeutics and Evofem Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Adaptimmune Therapeutics with a short position of Evofem Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Adaptimmune Therapeutics and Evofem Biosciences.

Diversification Opportunities for Adaptimmune Therapeutics and Evofem Biosciences

0.86

Correlation Coefficient

Adaptimmune Therapeutics  Evofem Biosciences

Very poor diversification

The 3 months correlation between Adaptimmune and Evofem is 0.86. Overlapping area represents the amount of risk that can be diversified away by holding Adaptimmune Therapeutics Plc and Evofem Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Evofem Biosciences and Adaptimmune Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Adaptimmune Therapeutics Plc are associated (or correlated) with Evofem Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Evofem Biosciences has no effect on the direction of Adaptimmune Therapeutics i.e., Adaptimmune Therapeutics and Evofem Biosciences go up and down completely randomly.

Pair Corralation between Adaptimmune Therapeutics and Evofem Biosciences

If you would invest  64.00  in Evofem Biosciences on September 4, 2024 and sell it today you would earn a total of  0.00  from holding Evofem Biosciences or generate 0.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	1.56%
Values	Daily Returns

Adaptimmune Therapeutics Plc  vs.  Evofem Biosciences

Adaptimmune Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Adaptimmune Therapeutics Plc has generated negative risk-adjusted returns adding no value to investors with long positions. Even with conflicting performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in January 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Evofem Biosciences

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Evofem Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound primary indicators, Evofem Biosciences is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.

Pair Trading with Adaptimmune Therapeutics and Evofem Biosciences

The main advantage of trading using opposite Adaptimmune Therapeutics and Evofem Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Adaptimmune Therapeutics position performs unexpectedly, Evofem Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Evofem Biosciences will offset losses from the drop in Evofem Biosciences' long position.

The idea behind Adaptimmune Therapeutics Plc and Evofem Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.